Mitigating potential risk for stakeholders in light of latest Sunshine Act developments.
Kim Schroer
Advertisement
Articles by Kim Schroer
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
3
Report: Richard Pazdur Out as Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
